Department of Basic and Oral Biology, Ribeirão Preto School of Dentistry, University of São Paulo, Brazil.
Department of Pediatric Clinics, School of Dentistry of Ribeirão Preto, USP - University of São Paulo, Brazil.
Microb Pathog. 2020 Dec;149:104477. doi: 10.1016/j.micpath.2020.104477. Epub 2020 Sep 10.
Candida albicans is the main causative agent of oral lesions in HIV-infected patients and its oral colonization is a potential source of systemic dissemination. Although the high prevalence of lesions in HIV patients can be explained by the immunosuppressive condition, several studies have reported that natural selection can make C. albicans more virulent in this group of patients. Comparisons of the activity of exoenzymes (phospholipase, proteinase and hemolysin) in C. albicans isolated from HIV-infected and uninfected patients have yielded conflicting results. This study aimed, through a systematic review and meta-analysis, to answer the question: "Is the hydrolytic enzymatic activity of C. albicans, isolated from the oral cavity, different in individuals infected and not infected with HIV?" The question was addressed using the PECO framework: P (Population): children and adults, E (Exposure): HIV infection, C (Comparator): non-HIV-infected patients; O (Outcomes): exoenzymes activity i.e. phospholipase, proteinase and hemolysin. We conducted a systematic search on Pubmed, Embase, Scopus, Livivo, Lilacs, Web of Science, and Science Direct databases, and Google Scholar. The MAStARI tool was used to evaluate the risk of bias in the selected studies. From 2259 studies, 19 were included in this review and 11 comprised the meta-analysis. The activity of phospholipase (M-H = 0.15; Z = 2,76; p = 0.0006) and hemolysin exoenzymes (M-H = 0.07; z = 1,94; p = 0.05) was higher in C. albicans isolated from the oral cavity of HIV-infected patients, whereas the levels of protease activity were not different compared with non-HIV-infected individuals. This study showed a higher phospholipase and hemolysin activity in C. albicans isolates from the oral cavity of HIV-infected patients.
白色念珠菌是 HIV 感染患者口腔病变的主要病原体,其口腔定植是全身播散的潜在来源。尽管 HIV 患者病变的高发生率可以用免疫抑制状态来解释,但有几项研究报告称,自然选择可以使白色念珠菌在这群患者中更具毒性。比较从 HIV 感染和未感染患者中分离出的白色念珠菌的外酶(磷脂酶、蛋白酶和溶菌酶)活性的研究结果相互矛盾。本研究通过系统评价和荟萃分析,旨在回答以下问题:“从口腔分离的白色念珠菌的水解酶活性在感染和未感染 HIV 的个体中是否不同?” 使用 PECO 框架来提出问题:P(人群):儿童和成人,E(暴露):HIV 感染,C(比较):未感染 HIV 的患者;O(结果):外酶活性,即磷脂酶、蛋白酶和溶菌酶。我们在 Pubmed、Embase、Scopus、Livivo、Lilacs、Web of Science 和 Science Direct 数据库以及 Google Scholar 上进行了系统检索。使用 MAStARI 工具评估所选研究的偏倚风险。从 2259 项研究中,有 19 项研究纳入本综述,11 项研究纳入荟萃分析。来自 HIV 感染患者口腔的白色念珠菌的磷脂酶活性(M-H=0.15;Z=2.76;p=0.0006)和溶菌酶外酶活性(M-H=0.07;Z=1.94;p=0.05)更高,而与未感染 HIV 的个体相比,蛋白酶活性没有差异。本研究表明,HIV 感染患者口腔白色念珠菌分离株的磷脂酶和溶菌酶活性更高。